1. Home
  2. COHN vs XTNT Comparison

COHN vs XTNT Comparison

Compare COHN & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Company Inc.

COHN

Cohen & Company Inc.

HOLD

Current Price

$11.99

Market Cap

54.3M

Sector

Finance

ML Signal

HOLD

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

HOLD

Current Price

$0.44

Market Cap

61.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHN
XTNT
Founded
1999
N/A
Country
United States
United States
Employees
N/A
151
Industry
Investment Bankers/Brokers/Service
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.3M
61.7M
IPO Year
2003
2009

Fundamental Metrics

Financial Performance
Metric
COHN
XTNT
Price
$11.99
$0.44
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
20.9K
129.0K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
4.35%
N/A
EPS Growth
5537.50
125.00
EPS
0.42
N/A
Revenue
$275,564,000.00
$53,337,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$9.30
P/E Ratio
$27.98
N/A
Revenue Growth
246.19
N/A
52 Week Low
$8.16
$0.43
52 Week High
$32.60
$0.95

Technical Indicators

Market Signals
Indicator
COHN
XTNT
Relative Strength Index (RSI) 45.00 40.61
Support Level $10.64 $0.44
Resistance Level $16.48 $0.67
Average True Range (ATR) 0.53 0.02
MACD 0.35 -0.00
Stochastic Oscillator 76.25 39.25

Price Performance

Historical Comparison
COHN
XTNT

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

Share on Social Networks: